Andrew says... Just fixed some audio issues some people have been seeing. If you're still having any audio problems, please comment!
Anand posts... The new header on top of all the modes should make it easier to focus on studying and switch between modes.
Log in to Join Options Log in to report a problem COP2014 pharmacy 143 Sets 33 Members Latest Alphabetical In April 2013 Pediatrics: Parenteral Nutrition 23 terms Special Pops: Pediactrics 22 terms Pharmacoeconomics, Chapter 8 9 terms Pharmacogenomics 44 terms In March 2013 Community (Class A) Pharmacy--G 67 terms Other Classes of Pharmacies--J 23 terms Other Classes of Pharmacies--J 23 terms FCSA/TCSA--B 111 terms TPA/TSBP Rules--D 138 terms TPA/TSBP Rules--D ABRIDGED 138 terms Geriatrics: Palliative Care 47 terms In February 2013 Pharmacoeconomics Chapter 7: Cost Benefit Analysis 30 terms Pharmacoeconomics Chapter 6: Cost Utility Analysis 34 terms Pharmacoeconomics Chapter 5: Cost Effectiveness Analysis 21 terms Pharmacoeconomics Chapter 4: Cost Minimization Analysis 6 terms Pharmacoeconomics, Chapter 2 29 terms In May 2012 Antifungals Ver.3 49 terms PT II Module 2c Drug-Disease Ver.6 170 terms Antifungals Ver. 2 49 terms PT II Module 2c Drug-Disease Ver.5 170 terms Parasitic Infections 60 terms In April 2012 Antiviral Med Chem Keyword Review 26 terms Hepatitis 30 terms AIDS Related Opportunistic Infections 34 terms Antiviral Structures 23 terms
Latest Alphabetical In April 2013 Pediatrics: Parenteral Nutrition 23 terms Special Pops: Pediactrics 22 terms Pharmacoeconomics, Chapter 8 9 terms Pharmacogenomics 44 terms In March 2013 Community (Class A) Pharmacy--G 67 terms Other Classes of Pharmacies--J 23 terms Other Classes of Pharmacies--J 23 terms FCSA/TCSA--B 111 terms TPA/TSBP Rules--D 138 terms TPA/TSBP Rules--D ABRIDGED 138 terms Geriatrics: Palliative Care 47 terms In February 2013 Pharmacoeconomics Chapter 7: Cost Benefit Analysis 30 terms Pharmacoeconomics Chapter 6: Cost Utility Analysis 34 terms Pharmacoeconomics Chapter 5: Cost Effectiveness Analysis 21 terms Pharmacoeconomics Chapter 4: Cost Minimization Analysis 6 terms Pharmacoeconomics, Chapter 2 29 terms In May 2012 Antifungals Ver.3 49 terms PT II Module 2c Drug-Disease Ver.6 170 terms Antifungals Ver. 2 49 terms PT II Module 2c Drug-Disease Ver.5 170 terms Parasitic Infections 60 terms In April 2012 Antiviral Med Chem Keyword Review 26 terms Hepatitis 30 terms AIDS Related Opportunistic Infections 34 terms Antiviral Structures 23 terms